Commit To Buy Corcept Therapeutics At $3, Earn 26.7% Annualized Using Options
January 05, 2015 at 11:38 AM EST
Investors considering a purchase of Corcept Therapeutics Inc (CORT) shares, but cautious about paying the going market price of $3.12/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put at the $3 strike, which has a bid at the time of this writing of 50 cents..